Xia, Yangliu
75  results:
Search for persons X
?
2

Hepatocyte CEBPA restricts the progression of liver fibrosi:

Yan, Tingting ; Yan, Nana ; Xia, Yangliu..
Drug Metabolism and Pharmacokinetics.  55 (2024)  - p. 100898 , 2024
 
?
3

Hepatocyte-specific CCAAT/enhancer binding protein α restri..:

Yan, Tingting ; Yan, Nana ; Xia, Yangliu...
Journal of Clinical Investigation.  134 (2024)  7 - p. , 2024
 
?
4

Drug-drug interaction potentials of tucatinib inhibition of..:

Lv, Xin ; Wang, Zhe ; Wang, Zhen...
Chemico-Biological Interactions.  381 (2023)  - p. 110574 , 2023
 
?
5

Inhibition of human UDP-glucuronosyltransferase enzyme by r..:

Lv, Xin ; Wang, Zhe ; Wang, Zhen...
Toxicology and Applied Pharmacology.  466 (2023)  - p. 116490 , 2023
 
?
6

Prediction of Drug–Drug Interaction Between Dabrafenib and ..:

Wang, Zhe ; Wang, Xiaoyu ; Wang, Zhen...
European Journal of Drug Metabolism and Pharmacokinetics.  47 (2022)  3 - p. 353-361 , 2022
 
?
9

Association between gene polymorphism and adverse effects i..:

Yan, Mingrui ; Fan, Xiaoyu ; Si, Hongyanhua...
Cancer Chemotherapy and Pharmacology.  89 (2022)  2 - p. 173-181 , 2022
 
?
10

Potential food-drug interaction risk of thymoquinone with w..:

Wang, Zhen ; Wang, Zhe ; Wang, Xiaoyu...
Chemico-Biological Interactions.  365 (2022)  - p. 110070 , 2022
 
?
11

Withaferin A alleviates ethanol-induced liver injury by inh..:

Hamada, Keisuke ; Wang, Ping ; Xia, Yangliu...
Food and Chemical Toxicology.  160 (2022)  - p. 112807 , 2022
 
?
15

The pathophysiological function of non-gastrointestinal far..:

Yan, Nana ; Yan, Tingting ; Xia, Yangliu...
Pharmacology & Therapeutics.  226 (2021)  - p. 107867 , 2021
 
1-15